Month: February 2021

NeuroRx Announced that RLF-100(TM) has Demonstrated Ten-Day Accelerated Recovery from Respiratory Failure among Patients with Severe Covid-19 Treated with HFNO at 28 Day Interim Endpoint

GENEVA, SWITZERLAND / ACCESSWIRE / February 24, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) ("Relief" or the "Company"), a biopharmaceutical...

DataLink’s Evoke360 Solution Receives NCQA HEDIS® Measurement Year 2020 Certification for Health Plan Measures and Allowable Adjustment Measures

TAMPA, Fla.--(BUSINESS WIRE)--#healthcaretechnology--DataLink Software (DataLink), a leading provider of integrated population health applications, interoperability, provider engagement and value-based care performance...

error: Content is protected !!